BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 10727454)

  • 1. Activation-induced inhibition of interleukin 6-mediated T cell survival and signal transducer and activator of transcription 1 signaling.
    Teague TK; Schaefer BC; Hildeman D; Bender J; Mitchell T; Kappler JW; Marrack P
    J Exp Med; 2000 Mar; 191(6):915-26. PubMed ID: 10727454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes.
    Ilangumaran S; Ramanathan S; La Rose J; Poussier P; Rottapel R
    J Immunol; 2003 Sep; 171(5):2435-45. PubMed ID: 12928391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages.
    Williams L; Bradley L; Smith A; Foxwell B
    J Immunol; 2004 Jan; 172(1):567-76. PubMed ID: 14688368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3.
    Niemand C; Nimmesgern A; Haan S; Fischer P; Schaper F; Rossaint R; Heinrich PC; Müller-Newen G
    J Immunol; 2003 Mar; 170(6):3263-72. PubMed ID: 12626585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.
    Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F
    Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.
    Hong F; Jaruga B; Kim WH; Radaeva S; El-Assal ON; Tian Z; Nguyen VA; Gao B
    J Clin Invest; 2002 Nov; 110(10):1503-13. PubMed ID: 12438448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways.
    Ahmed ST; Ivashkiv LB
    J Immunol; 2000 Nov; 165(9):5227-37. PubMed ID: 11046056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine-induced Src homology 2 protein (CIS) promotes T cell receptor-mediated proliferation and prolongs survival of activated T cells.
    Li S; Chen S; Xu X; Sundstedt A; Paulsson KM; Anderson P; Karlsson S; Sjögren HO; Wang P
    J Exp Med; 2000 Mar; 191(6):985-94. PubMed ID: 10727460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners.
    Sun R; Tian Z; Kulkarni S; Gao B
    J Immunol; 2004 May; 172(9):5648-55. PubMed ID: 15100309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1.
    Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C
    J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymocytes between the beta-selection and positive selection checkpoints are nonresponsive to IL-7 as assessed by STAT-5 phosphorylation.
    Van De Wiele CJ; Marino JH; Murray BW; Vo SS; Whetsell ME; Teague TK
    J Immunol; 2004 Apr; 172(7):4235-44. PubMed ID: 15034036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.
    Chen T; Wang LH; Farrar WL
    Cancer Res; 2000 Apr; 60(8):2132-5. PubMed ID: 10786674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of signal transducer and activator transcription factor 3 in rats with acute hepatic failure.
    Kamohara Y; Sugiyama N; Mizuguchi T; Inderbitzin D; Lilja H; Middleton Y; Neuman T; Demetriou AA; Rozga J
    Biochem Biophys Res Commun; 2000 Jun; 273(1):129-35. PubMed ID: 10873574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.
    Shen X; Tian Z; Holtzman MJ; Gao B
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):913-9. PubMed ID: 11104703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein tyrosine phosphatase epsilonC selectively inhibits interleukin-6- and interleukin- 10-induced JAK-STAT signaling.
    Tanuma N; Shima H; Nakamura K; Kikuchi K
    Blood; 2001 Nov; 98(10):3030-4. PubMed ID: 11698287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and function of a new STAT-induced STAT inhibitor.
    Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T
    Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.
    Ding Y; Chen D; Tarcsafalvi A; Su R; Qin L; Bromberg JS
    J Immunol; 2003 Feb; 170(3):1383-91. PubMed ID: 12538698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.
    Delgado M; Ganea D
    J Immunol; 2000 Sep; 165(6):3051-7. PubMed ID: 10975815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells.
    Kamiya S; Owaki T; Morishima N; Fukai F; Mizuguchi J; Yoshimoto T
    J Immunol; 2004 Sep; 173(6):3871-7. PubMed ID: 15356135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.